These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 520130)

  • 1. Proceedings of the Kroc Foundation International Conference on Epidemiology of Diabetes and its Macrovascular Complication.
    Diabetes Care; 1979; 2(2):63-249. PubMed ID: 520130
    [No Abstract]   [Full Text] [Related]  

  • 2. Proceedings of a conference on diabetic microangiopathy. The Second Kroc Foundation Conference. May 17-20, 1982, Santa Ynez, California.
    Diabetes; 1983 May; 32 Suppl 2():1-104. PubMed ID: 6600034
    [No Abstract]   [Full Text] [Related]  

  • 3. Diabetes in Africa. Diabetes microvascular and macrovascular disease in Africa.
    Mbanya JC; Sobngwi E
    J Cardiovasc Risk; 2003 Apr; 10(2):97-102. PubMed ID: 12668906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proceedings of a conference on insulin pump therapy in diabetes. Multicenter study of effect on microvascular disease. Introduction. The Kroc Collaborative Study Group.
    Diabetes; 1985 Aug; 34 Suppl 3():1-4. PubMed ID: 4018418
    [No Abstract]   [Full Text] [Related]  

  • 5. Hyperinsulinemia as a possible risk factor of macrovascular disease in diabetes mellitus. Proceedings of an international workshop. Saint-Paul-de-Vence, Nice, France, January 29-30, 1987.
    Diabete Metab; 1987 Jul; 13(3 Pt 2):277-394. PubMed ID: 3308555
    [No Abstract]   [Full Text] [Related]  

  • 6. [A nationwide retrospective analysis on chronic diabetic complications and related macrovascular diseases of in-patients with diabetes during 1991-2000].
    ;
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2002 Oct; 24(5):447-51. PubMed ID: 12905762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New-onset diabetes after transplantation: 2003 International consensus guidelines. Proceedings of an international expert panel meeting. Barcelona, Spain, 19 February 2003.
    Davidson J; Wilkinson A; Dantal J; Dotta F; Haller H; Hernández D; Kasiske BL; Kiberd B; Krentz A; Legendre C; Marchetti P; Markell M; van der Woude FJ; Wheeler DC;
    Transplantation; 2003 May; 75(10 Suppl):SS3-24. PubMed ID: 12775942
    [No Abstract]   [Full Text] [Related]  

  • 8. [Macroangiopathic complications in type 2 diabetic patients seen at an Italian diabetes center].
    Maggini M; Spila Alegiani S; Raschetti R
    Ann Ist Super Sanita; 2003; 39(2):165-71. PubMed ID: 14587214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiological studies on the effects of hyperglycemia and improvement of glycemic control on macrovascular events in type 2 diabetes.
    Haffner SM
    Diabetes Care; 1999 Apr; 22 Suppl 3():C54-6. PubMed ID: 10189563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Epidemiology of cardiovascular complications of diabetes].
    Brun JM; Passa P; Sauvanet JP; Berthezene F; Komajda M
    Diabetes Metab; 1999 Jun; 25 Suppl 3():5-6. PubMed ID: 10421987
    [No Abstract]   [Full Text] [Related]  

  • 11. Five-year incidence of major macrovascular complications in diabetes mellitus.
    Janka HU
    Horm Metab Res Suppl; 1985; 15():15-9. PubMed ID: 3865879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of stroke, heart attack, and diabetes complications among veterans with spinal cord injury.
    Banerjea R; Sambamoorthi U; Weaver F; Maney M; Pogach LM; Findley T
    Arch Phys Med Rehabil; 2008 Aug; 89(8):1448-53. PubMed ID: 18674979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Epidemiology of arteriosclerosis in diabetes mellitus].
    Panzram G
    Verh Dtsch Ges Inn Med; 1987; 93():427-33. PubMed ID: 3327293
    [No Abstract]   [Full Text] [Related]  

  • 14. [Epidemiology of cardio-vascular complications of diabetes].
    Grimaldi A; Heurtier A
    Diabetes Metab; 1999 Jun; 25 Suppl 3():12-20. PubMed ID: 10421988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology of diabetes mellitus and its cardiovascular manifestations.
    West KM
    Prog Clin Biol Res; 1979; 32():553-65. PubMed ID: 523485
    [No Abstract]   [Full Text] [Related]  

  • 16. The metabolic syndrome is a risk indicator of microvascular and macrovascular complications in diabetes: results from Metascreen, a multicenter diabetes clinic-based survey.
    ; Bonadonna R; Cucinotta D; Fedele D; Riccardi G; Tiengo A
    Diabetes Care; 2006 Dec; 29(12):2701-7. PubMed ID: 17130208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Epidemiology of the complication of coronary atherosclerosis: some results of the prospective Paris study].
    Ducimetière P; Richard J; Eschwege E; Claude J; Rosselin G
    Journ Annu Diabetol Hotel Dieu; 1982; ():257-64. PubMed ID: 7098251
    [No Abstract]   [Full Text] [Related]  

  • 18. Serum sialic acid and carbohydrate-deficient transferrin concentration in Type 2 diabetes mellitus with and without macrovascular complications.
    Chrostek L; Cylwik B; Poplawska A; Szmitkowski M; Koput A
    Diabetes Nutr Metab; 2004 Dec; 17(6):371-3. PubMed ID: 15887632
    [No Abstract]   [Full Text] [Related]  

  • 19. Macrovascular disease in diabetes mellitus. Pathogenesis and prevention. International workshop, Garmisch-Grainau, October 1984.
    Horm Metab Res Suppl; 1985; 15():1-122. PubMed ID: 3865875
    [No Abstract]   [Full Text] [Related]  

  • 20. [Prevalence of microvascular and macrovascular complications in hospitalized diabetic patients].
    Bompiani G; Rinaldi A; Bongiovì A; Bozzotta S; Di Fiore C; Zarcone MR
    Recenti Prog Med; 1988 Apr; 79(4):164-8. PubMed ID: 3393726
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.